Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.84 – $1.17
0% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.83B | $13.02B | $13.85B | $15.47B | $16.91B | $16.78B | $18.61B | $17.52B |
| Cost of revenue | $4.12B | $4.87B | $5.28B | $5.92B | $6.69B | $6.51B | $6.68B | $6.51B |
| Gross profit | $7.71B | $8.15B | $8.58B | $9.56B | $10.22B | $10.27B | $11.93B | $11.01B |
| Gross margin | 65.1% | 62.6% | 61.9% | 61.7% | 60.4% | 61.2% | 64.1% | 62.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $2.30B | $2.33B | $2.93B | $2.99B | $3.32B | $3.27B | $3.91B | $3.76B |
| EBITDA | $2.34B | $2.28B | $2.79B | $2.92B | $3.00B | $2.89B | $4.14B | $4.13B |
| Net income | $1.11B | $782.8M | $1.40B | $1.31B | $1.40B | $1.11B | $1.49B | $1.61B |
| Net margin | 9.4% | 6.0% | 10.1% | 8.4% | 8.3% | 6.6% | 8.0% | 9.2% |
| EPS (diluted) | 1.09 | 0.76 | 1.39 | 1.30 | 1.40 | 1.15 | 1.53 | 1.65 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $18.6B | $2.13 | $1.99–$2.32 | 1 |
| 2027 | $19.3B | $2.18 | $2.04–$2.37 | 1 |
| 2028 | $20.7B | $2.54 | $2.37–$2.77 | 1 |
| 2029 | $23.2B | $3.01 | $2.81–$3.27 | 1 |
Forward consensus · source: Financial Modeling Prep
GENOMMA LAB INTL SAB ORD
No one on the platform currently holds GNMLF.
No tracked institution reports a position in GNMLF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-26 | $0.2000 | 2026-06-29 |
| 2026-03-30 | $0.2000 | 2026-03-31 |
| 2025-12-22 | $0.2000 | 2025-12-23 |
| 2025-09-18 | $0.2000 | 2025-09-19 |
| 2025-06-30 | $0.2000 | 2025-07-01 |
| 2025-03-13 | $0.2000 | 2025-03-14 |
| 2024-12-17 | $0.2000 | 2024-12-18 |
| 2024-09-13 | $0.2000 | 2024-09-17 |
| 2024-06-20 | $0.2000 | 2024-06-21 |
| 2024-03-21 | $0.1961 | 2024-03-25 |
No one on the platform has traded GNMLF yet.
| +0.00% |
| $1.2B |
| — |
| NWKHYNetcare Limited | $7.17 | +0.00% | $844M | — |
| RHKJFRhoen-Klinikum AG | $15.30 | +0.00% | $1.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-22 |
| $0.1961 |
| 2023-12-27 |
| 2023-09-27 | $0.1961 | 2023-09-29 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.4× earnings vs its 0.7× historical median P/E.
Fair value ≈ $1.61 · price $0.84 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.